参考文献：[1] Synthesis, 1988, #6, p.456-459；[2] Bioorganic and Medicinal Chemistry Letters, 2006, vol.16, #14, p.3706-3712；[3] Bioorganic and Medicinal Chemistry Letters, 2008, vol.18, #2, p.634-639；[4] Journal of the Chemical Society, 1955, p.803；[5] Journal of Organic Chemistry USSR (English Translation), 1991, vol.27, #1.2, p.177-182；[6] Zhurnal Organicheskoi Khimii, 1991, vol.27, #1, p.201-206；[7] Zeitschrift fuer Naturforschung, Teil B: Anorganische Chemie, Organische Chemie, 1986, vol.41, #1, p.101-104；[8] Journal of Medicinal Chemistry, 1997, vol.40, #12, p.1901-1905；[9] Bioorganic and Medicinal Chemistry Letters, 2003, vol.13, #16, p.2641-2645；[10] European Journal of Medicinal Chemistry, 2003, vol.38, #3, p.313-318；[11] Phosphorus, Sulfur and Silicon and the Related Elements, 2006, vol.181, #6, p.1381-1389；[12] Bioorganic and Medicinal Chemistry Letters, 2005, vol.15, #12, p.3081-3085；[13] Heteroatom Chemistry, 2009, vol.20, #7, p.418-424；[14] Patent: US7105508, 2006, B1；[15] Bioorganic and Medicinal Chemistry, 2013, vol.21, #21, p.6385-6397；[16] MedChemComm, 2016, vol.7, #9, p.1768-1774；[17] Patent: WO2018/89261, 2018, A2
路线2：
原料：1-苯甲酰-3-(2-吡啶基)-2-硫脲（即N-（吡啶-2-基硫代甲酰基）苯甲酰胺）
步骤：同路线1步骤
条件：同路线1条件
收率：未提供
参考文献：[1] European Journal of Medicinal Chemistry, 2016, vol.119, p.83-95
路线3：
原料：N-（吡啶-2-基硫代甲酰基）苯甲酰胺（2.3g，8.95mmol）
步骤：同路线1步骤
条件：同路线1条件
收率：未提供
参考文献：[1] Phosphorus, Sulfur and Silicon and the Related Elements, 2006, vol.181, #7, p.1665-1673；[2] New Journal of Chemistry, 2018, vol.42, #15, p.12649-12665；[3] European Journal of Medicinal Chemistry, 2004, vol.39, #10, p.867-872；[4] European Journal of Medicinal Chemistry, 2008, vol.43, #4, p.749-754；[5] European Journal of Medicinal Chemistry, 2009, vol.44, #3, p.1100-1105
